EQ: Equillium, Inc. Stock

by  •  • Comments Off on EQ: Equillium, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 26.22
Enterprise Value ($M) 0.34
Book Value ($M) 23.18
Book Value / Share 0.65
Price / Book 1.13
NCAV ($M) 22.70
NCAV / Share 0.64
Price / NCAV 1.15

Profitability (mra)
Return on Invested Capital (ROIC) -0.19
Return on Assets (ROA) -0.08
Return on Equity (ROE) -0.19

Liquidity (mrq)
Quick Ratio 3.07
Current Ratio 3.07

Balance Sheet (mrq) ($M)
Current Assets 33.98
Assets 34.46
Liabilities 11.28
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Decheng Capital Management IV (Cayman), LLC 15.60
01-19 13G Takeda Pharmaceutical Co Ltd 5.20

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-26 23,336 83,087 28.09
2024-11-25 30,319 105,839 28.65
2024-11-22 20,608 49,199 41.89
2024-11-21 26,916 123,452 21.80

(click for more detail)

Similar Companies
ENTX – Entera Bio Ltd. ENVB – Enveric Biosciences, Inc.
EPIX – ESSA Pharma Inc. ERNA – Eterna Therapeutics Inc.
ESLA – Estrella Immunopharma, Inc.


Financial data and stock pages provided by
Fintel.io